2008
CF PharmTech was founded in Wuxi, Jiangsu province in 2008.
Through rapid growth, it becomes a fully integrated specialty pharmaceutical company dedicated to providing high-quality respiratory drugs for the global market.
Managed by a high-caliber team with extensive experience in the industry, the company focuses on the development of drugs for the treatment of respiratory diseases in its state-of-the-art facilities.
Our mission
Our mission is to develop high-quality and affordable products to treat respiratory diseases and help patients to breathe easier and live better.
Our values
Integrity
Patient Focus
Science-led Innovation
Our History
2008
CF PharmTech was founded under Wuxi "530” Sponsorship Program
2009
Received Jiangsu Provincial Innovation Award, and Science and Technology Leader Team Award
2010
Secured a A-series capital investment, signed strategic partnership deal with Beijing SL Pharmaceutical
2011
Wholly-owned subsidiary-Jiangsu CF PharmTech was set up in Wuxi; Filed 5 patents in China
2013
Secured a B-series capital investment, startup Suzhou CF PharmTech
2014
Completed the construction of Suzhou CF PharmTech
2015
Secured a C-series capital investment, established the nasal spray and DPI production line
2017
Secured a D-series capital investment of USD65 million
2018
Secured a E-series capital investment of USD94 million
2020
Secured a F-series capital investment of USD50 million
2021
Budesonide Suspension for Inhalation and Salbutamol Sulfate inhalation solution were approved for market.